Research programme: Avibody-based imaging agents - Avipep/Sanofi

Drug Profile

Research programme: Avibody-based imaging agents - Avipep/Sanofi

Alternative Names: 89Zr-Avibodies

Latest Information Update: 13 Jul 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Avipep
  • Developer Avipep; Sanofi
  • Class Imaging agents; Radiopharmaceutical diagnostics
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Research Unspecified

Most Recent Events

  • 13 Jul 2015 Early research in Undefined indication (Diagnosis) in Australia (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top